Why people use Semaglutide for PCOS
PCOS + insulin resistance + weight. Semaglutide vs Tirzepatide? The honest answer: this is an emerging off-label use, early and unproven. Off-label use; widely prescribed for PCOS-associated metabolic dysfunction.
This page covers what's known, what's not, and what the editorial take is for normal humans considering Semaglutide for PCOS.
What the evidence says
Evidence tier: Off-label · emerging. Off-label clinical use with emerging evidence; not FDA-approved for this indication specifically.
- Off-label use; widely prescribed for PCOS-associated metabolic dysfunction.
- Smaller weight-loss effect vs Tirzepatide but more years of safety data.
- Emerging evidence for cycle regularity and ovulation improvement.
Protocol notes
Standard weight-loss titration. Coordinate with reproductive endocrinology if pregnancy planning.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full Semaglutide directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch